PLATEAU STATE GOVERNOR SEEKS DEEPER SECURITY COLLABORATION WITH NAF. (PHOTOS). #PRESS RELEASE.

Image
PLATEAU STATE GOVERNOR SEEKS DEEPER SECURITY COLLABORATION WITH NAF In a bid to reinforce internal security and deepen intergovernmental collaboration, the Executive Governor of Plateau State, His Excellency Barrister Caleb Manasseh Mutfwang, on Tuesday, 16 December 2025, paid a courtesy visit to the Nigerian Air Force (NAF) Headquarters, Abuja, where he met with the Chief of the Air Staff (CAS), Air Marshal Sunday Kelvin Aneke, DFS. The visit underscored the Governor’s commitment to leveraging strategic federal partnerships to address evolving security challenges in Plateau State and the wider North Central region, while conveying the goodwill of the government and people of the state and congratulating the CAS on his appointment as the 23rd Chief of the Air Staff. Governor Mutfwang commended the Nigerian Air Force for its sustained efforts in maintaining peace and responding to security threats in Plateau State, acknowledging the complexity of the operating environment. He noted that...

DEXAMETHASONE IS THE CURE TO COVID-19 AS 'WHO' WELCOMES PRELIMINARY RESULTS ABOUT THE USE OF THE DRUG IN TREATING CRITICALLY ILL COVID-19 PATIENTS.{PHOTOS}.#PRESS RELEASE.

What is Dexamethasone? | What Is News,The Indian Express
     The World Health Organization (WHO) welcomes the initial clinical trial results from the United Kingdom (UK) that show dexamethasone, a corticosteroid, can be lifesaving for patients who are critically ill with COVID-19. For patients on ventilators, the treatment was shown to reduce mortality by about one third, and for patients requiring only oxygen, mortality was cut by about one fifth, according to preliminary findings shared with WHO.
The benefit was only seen in patients seriously ill with COVID-19, and was not observed in patients with milder disease. 
“This is the first treatment to be shown to reduce mortality in patients with COVID-19 requiring oxygen or ventilator support,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “This is great news and I congratulate the Government of the UK, the University of Oxford, and the many hospitals and patients in the UK who have contributed to this lifesaving scientific breakthrough.”
Dexamethasone is a steroid that has been used since the 1960s to reduce inflammation in a range of conditions, including inflammatory disorders and certain cancers. It has been listed on the WHO Model List of Essential Medicines since 1977 in multiple formulations, and is currently off-patent and affordably available in most countries.


The researchers shared initial insights about the results of the trial with WHO, and we are looking forward to the full data analysis in the coming days. WHO will coordinate a meta-analysis to increase our overall understanding of this intervention. WHO clinical guidance will be updated to reflect how and when the drug should be used in COVID-19.One more photo below.
What is Dexamethasone, does it treat coronavirus and what is it ...

Comments

Popular posts from this blog

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

THE NEW OONI OF ILE-IFE,WILL NOT EAT THE HEART OF THE LATE OONI-PALACE CHIEFS.